Vimovo
Product Images NDC 16590-957

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vimovo (NDC 16590-957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Vimovo Label 957)

This is a description of a drug package containing tablets that may cause some side effects such as hives, headaches, dry mouth, nausea, and diarrhea. The tablets contain Naproxen and Esomeprazole Magnesium. The manufacturer is AstraZeneca LP in Wilmington, DE, with Lot number WHos2 4. The NDC number is 1659095760. The tablets are a delayed-release formula with each tablet containing Naproxen 375mg/22.3mg and Esomeprazole magnesium equivalent to 20mg of Esomeprazole.*

FDA Label Image

Figure 1 (Vimovo Figureone)

FDA Label Image

Naproxen Structure (Vimovo Structureone)

FDA Label Image

Esomeprazole Structure (Vimovo Structuretwo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.